Daiichi Sankyo Buys Controlling Stake In Ranbaxy

In an effort to diversify and increase its presence in emerging markets, Japanese drugmaker Daiichi Sankyo has purchased a controlling stake in Indian generics firm Ranbaxy Laboratories. Closure of the deal is expected by March 2009 and the purchase price will be up to US$4.6bn.

To read the full article, please choose one of the following options: